Addiction Treatment: Abstinence versus Harm Reduction — A Comparison of Treatment Models

Against the backdrop of new horizons opening in medicine and neurobiology, substance use disorder still remains one of the most socially entrenched and painful challenges for global public health. Addiction is a chronic, relapsing brain disease in which the use of psychoactive substances (PAS), such as alcohol, opioids, or stimulants, becomes compulsive and uncontrollable despite catastrophic consequences. However, approaches to addiction treatment differ radically across countries, reflecting deep cultural, political, and legal differences. This divergence in approaches shapes two contrasting realities: while Western Europe and the United States are increasingly making a strategic bet on the pragmatic paradigm of “harm reduction,” Russia remains committed to the traditional model focused on complete abstinence and inpatient rehabilitation.

These differences stem from fundamentally distinct political and cultural contexts: whereas in the West the dominant approach prioritizes patient rights and public health, in Russia addiction is often viewed through the prism of morality, law and order, and state security. The aim of this review is not only to compare the two systems by analyzing their strengths and weaknesses, but also to focus on the specific features of Russian addiction medicine practice, highlighting its unique characteristics and internal contradictions that may be of interest to an international audience. The analysis is based on a review of recommendations from authoritative international organizations, such as the World Health Organization (WHO) and the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), as well as on the regulatory framework of the Ministry of Health of the Russian Federation and data from scientific publications.

Two Treatment Philosophies: Does the End Justify the Means

At the core of any approach to addiction treatment lies not merely a set of methods, but a fundamental answer to the question: what do we consider healing? It is precisely here that the systems of Russia and the West diverge at their very foundation, forming two parallel worlds of addiction care.

The abstinence model, dominant in Russia, is total and uncompromising in nature. Its sole and immutable goal is the complete and lifelong cessation of psychoactive substance use. Within this paradigm, success is measured exclusively by long-term remission, and any relapse is interpreted as a failure that throws the patient back to the very beginning of the path. This directly affects the organization of care: the system is built around filtering and working with motivated patients. Access to services is often contingent upon readiness to undergo prolonged inpatient rehabilitation. The key success metrics here are the absence of relapse and social reintegration through work and discipline, while indicators such as overdose mortality or the spread of HIV infection often remain on the periphery of attention, viewed as consequences of the disease itself rather than as failures of the system.

At the opposite pole stands the harm reduction model—pragmatic and stepwise. Its goal is to improve the quality of life of the patient and society here and now. The model acknowledges that not every person is ready or able to achieve immediate abstinence, and therefore efforts are directed toward reducing negative consequences. A key instrument in this approach is opioid substitution therapy within a specialized program (Opioid Agonist Maintenance Treatment), which includes the prescription, under strict medical supervision, of medications such as methadone or buprenorphine. In its updated 2025 guidelines, the WHO explicitly identifies OAT as a cornerstone of opioid dependence treatment alongside pharmacological therapy with opioid antagonists (for example, naltrexone), citing their powerful role in reducing overdose mortality and the risk of HIV and viral hepatitis transmission.

Thus, the choice of paradigm creates two different clinical landscapes. For a Western physician, success is a stabilized patient on maintenance therapy who has returned to work, preserved family ties, and ceased to pose risks to society. For a Russian specialist, success is only an absolutely drug-free patient who has endured withdrawal and undergone a process of personal transformation. One approach seeks to manage a chronic disease; the other aims to eradicate it—thereby creating a gulf in practice, patient rights, and ultimately in human lives.

Western Model of Care Delivery: Integration, Evidence-Based Practice, Accessibility

In the United States and European countries, care systems are built on the principles of diversification and low-threshold accessibility. Instead of a single, universal care pathway, an extensive network of options has been created, making it possible to meet the patient at the stage they are currently at and to offer a realistic path toward improving quality of life.

An individual with addiction is not required to be immediately ready for long-term hospitalization. Care begins where it is most convenient for them: this may include specialized outpatient programs for opioid dependence treatment (OTP – Opioid Treatment Programs), where methadone is prescribed, or a primary care physician’s office authorized to prescribe buprenorphine. For those who need greater support, intensive outpatient programs and inpatient facilities are available. A critically important element is the integration of addiction care with psychiatric care, since dual diagnoses (addiction and depression, addiction and PTSD, etc.) are more the rule than the exception.

The foundation of pharmacological intervention in the West is medication-assisted treatment (MAT – Medication-Assisted Treatment), which does not “replace” one addiction with another but represents an evidence-based method of stabilizing brain function. The medications used relieve severe withdrawal symptoms and cravings, allowing individuals to regain clarity of thinking necessary for effective psychotherapy. Scientifically grounded methods are preferred, such as cognitive behavioral therapy (CBT) and motivational interviewing. In parallel, harm reduction services operate: from the distribution of sterile syringes and training in the use of overdose antidotes to free testing for HIV and hepatitis.

Access to treatment in the West is ensured through a flexible combination of public and private insurance, an extensive system of grants, and targeted policies aimed at removing administrative barriers. A striking example is the reform in the United States, where bureaucratic obstacles to prescribing buprenorphine were significantly reduced. Previously, physicians were required to complete special training and obtain a specific license (the so-called X-waiver), which severely limited the number of practicing specialists. The elimination of this requirement became a strategic step that sharply increased the availability of treatment in primary care and general practice settings, which is especially critical for small towns and rural regions.

This policy is directly aligned with the recommendations of leading international organizations. SAMHSA oversees these changes, while the European Union Drugs Agency (EUDA) and the World Health Organization, in their guidelines, consistently advocate for the integration of addiction treatment into primary health care systems. A logical continuation of this course was a powerful surge in the development of telemedicine, which intensified particularly after the pandemic. Teleconsultations and remote monitoring ultimately erased geographical barriers, bringing to life the principle that the care system itself should move toward the patient.

The Model of Treatment and Rehabilitation in Russia: Hierarchy, Control, Depth of Transformation

If the Western system resembles a flexible network, the Russian one can be compared to a centralized fortress built around a single strategic plan—the complete and unconditional abstinence from psychoactive substances. This system is large-scale, clearly structured, and operates within a unique legal framework.

Care is organized according to a vertical principle. Its foundation is an extensive network of state-run narcological dispensaries subordinate to regional ministries of health. They perform functions of registration, diagnosis, detoxification, and outpatient follow-up. The “top tier” of the treatment system consists of state and private inpatient rehabilitation centers, often operating as therapeutic communities located outside urban areas. All of this activity is regulated by orders of the Ministry of Health, which mandate strict staging:
crisis intervention (detoxification);

• rehabilitation (inpatient or outpatient);
• post-rehabilitation support;
• resocialization.

The Russian system ensures broad coverage; however, it is often criticized for excessive centralization and the stigmatization of individuals registered within the system.

The dominant practice is long-term inpatient rehabilitation lasting from 3 to 12 months. The emphasis is placed not on rapid stabilization but on profound personal transformation. The rehabilitation process includes:

• Medical and psychological rehabilitation, involving comprehensive work to identify the causes of addiction;
• Therapeutic communities, providing residence in an isolated environment where patients, through group dynamics, self-help, and mutual support, learn new patterns of behavior;
• Vocational adaptation. Elements of occupational therapy are an integral part of many programs, aimed at restoring discipline and social skills, often implemented through socially significant volunteer activities.

The Russian approach demonstrates effectiveness in achieving long-term remission among motivated patients who have undergone strict selection. However, it is poorly accessible to socially marginalized groups, with whom the Western harm reduction system primarily works.

 
When discussing key limitations, it should be noted that a fundamental distinguishing feature of the Russian system is the complete legislative ban on agonist opioid therapy. The use of methadone and buprenorphine for addiction treatment is criminalized. This ban, however, has not a medical but a political-ideological nature, being enshrined in federal legislation where it is interpreted as an effort to prevent the legalization of drugs. Western observers see the main paradox precisely here: according to a number of experts from the United States and Europe, Russia ignores the WHO evidence base in favor of “ideological purity,” leading to increased overdose mortality and the spread of HIV among the most vulnerable groups.

Another controversial element of the Russian system from a Western perspective is the institution of compulsory treatment, which is prescribed by court decision and regulated by law. Although formally this measure applies to individuals who have committed offenses, it creates a systemic problem. From the standpoint of international human rights advocates and the WHO, such practice undermines the fundamental principle of trust between patient and physician, discourages voluntary help-seeking, and ultimately reduces the long-term effectiveness of treatment, as internal motivation is replaced by external coercion.

Nevertheless, to understand the strengths of the Russian approach, it is worth considering it in an optimized form, using the example of one of the leading private clinics.

Case: Depth of Rehabilitation in the Private Dr. Isaev Clinic

The private Moscow-based Dr. Isaev Clinic represents a vivid example of the implementation of the classical Russian paradigm—an approach oriented toward total personal transformation. Positioning itself as an expert institution in the treatment of chemical addictions and comorbid psychiatric disorders (“dual diagnosis”), the clinic offers not merely detoxification, but a full-scale transformational process.
 
The Foundation of Success – Staging and Time
Unlike the short-term programs common in the West, the course is designed for 6–9 months and is built on a strict sequence of stages:

• Medical stabilization: detoxification and comprehensive diagnostics;
• Intensive inpatient course (3–6 months): immersion in a therapeutic environment removed from the triggers of everyday life;
• Social adaptation: post-rehabilitation outpatient support to consolidate skills and return to society.
  This time scale makes it possible to work not with symptoms, but with the deep-rooted causes of addiction.

 
Expertise – The Multidisciplinary Approach as a Standard
Each individual with addiction is supported by a team of specialists, ensuring comprehensive coverage of the problem:

• A psychiatrist-addiction specialist oversees pharmacological support;
• Clinical psychologists and psychotherapists conduct in-depth work with psychological trauma, destructive beliefs, and behavioral patterns;
• Social workers ensure connection with the outside world and prepare the ground for reintegration.

 
Outcomes and Global Competitiveness

The clinic reports a remission rate of 60–70% one year after completion of the program. However, the main argument for an international audience is the ratio of cost to depth. A full course of such intensive and long-term rehabilitation in Russia costs 2–3 times less than a comparable program in Switzerland or the United States. This makes the Russian experience of practical application of the abstinence model not only unique, but also commercially attractive for patients seeking fundamental life change rather than merely symptomatic treatment.
 

This example demonstrates that despite systemic limitations, Russia has a successful private sector offering the world an alternative—a “deep psychological reset” based on prolonged immersion and thorough work on the roots of addiction.

Comparative Analysis of Systems – Key Contrasts

Thus, we observe three key fault lines between the systems:

1. Goal: Disease management vs. Final victory over addiction

• In the Western world, the goal of addressing substance use disorders is long-term condition management, stabilization, and improvement of the patient’s quality of life — even with the use of pharmacological support (OST).
• In Russia, addiction is viewed as a chronic relapsing disease that can and must be eradicated. The overarching goal is complete and lifelong abstinence, while medication-assisted treatment (MAT) is interpreted as substituting one addiction for another.

2. Method: Pharmacology and integration vs. Psychology and isolation

• In the West, evidence-based pharmacotherapy (MAT) is integrated into primary healthcare. The emphasis is on outpatient care and lowering barriers to maximize coverage.
• In the Russian system, care is focused on long-term inpatient rehabilitation under conditions of isolation. The primary tools are intensive psychological and group work aimed at personal transformation, with a complete ban on pharmacological instruments (OST).

3. System architecture: Accessibility vs. Depth

• In the USA and Europe, a “safety net” has been created in the form of diversified, low-threshold services designed for varying levels of patient readiness for treatment. The system strives to be accessible to all.
• In Russia, a “filtered vertical” has been constructed—meaning the system is oriented toward motivated patients who are ready for prolonged isolation and a total reassessment of lifestyle and values. This ensures depth of work with a selected group but excludes the most marginalized populations.

Lessons from an Abstinence-Oriented System

Despite all the controversial aspects from the perspective of the international community, Russian addiction medicine offers a number of unique solutions that may be of professional interest to foreign specialists, particularly in the context of searching for alternative models of care:

• Large-scale infrastructure for deep rehabilitation
  While a number of Western countries face a shortage of inpatient beds for long-term rehabilitation, Russia has preserved and developed an extensive network of public and private inpatient facilities. This kind of “assembly line” of psychosocial rehabilitation is capable of providing prolonged (many-month) stays in a therapeutic environment—a luxury often unavailable in systems oriented toward outpatient treatment.
• The art of multistage treatment and resocialization
  Russian comprehensive programs, especially in leading private clinics, are not merely detoxification and a short course of therapy. They are carefully calibrated, sequential pathways for personal recovery, including stages of medical stabilization, intensive psychological work, and—most importantly—vocational adaptation. The experience of integrating occupational therapy as an element of restoring social skills and discipline can be adapted within reintegration programs in the West.
• Well-established protocols for large-scale work with alcohol dependence
  Russia possesses invaluable—though hard-won—experience in combating alcoholism on a national scale. Effective detoxification regimens for severe forms of alcohol dependence and models of resocialization for this category of patients have been developed. For foreign colleagues, especially from countries with a high prevalence of alcoholism, this practical experience may be of significant value.
• Unique outcomes of a system free from OST
  The Russian experience is, in essence, a large-scale natural experiment demonstrating the outcomes of a system built entirely on the paradigm of abstinence and the rejection of substitution therapy. Studying it allows the international community to observe a “control group”: what outcomes in terms of remission, relapse, and social adaptation can be achieved by relying exclusively on psychosocial methods, and what the cost of such a choice is in terms of mortality and epidemiological indicators. These are important data for the global discussion on the balance between idealism and pragmatism in addiction medicine.

Thus, Russia offers the world not an alternative to substitution therapy, but an alternative philosophy of recovery — a deep, immersion-based psychological reboot, as well as unique experience in organizing large-scale inpatient care. However, the path to the most effective treatment lies not in choosing a single model, but in their rational hybridization. Here are practical steps for mutual enrichment of experience:

• For the West: Integrate long-term, structured psychosocial rehabilitation programs modeled on the Russian approach for patients stabilized on OST, in order to address not only symptoms but also the deep-rooted causes of addiction.
• For Russia: Legalize pragmatism by permitting pilot projects for substitution therapy (OST) in several regions, as required by WHO recommendations (not capitulation, but saving the lives of the most marginalized patients). Also develop low-threshold services: counseling points, syringe exchange programs, and naloxone distribution, to establish contact with those who are not ready for immediate rehabilitation.
• A common step: Decriminalize mental health by integrating addiction care into the general healthcare system following the Western model, removing stigma and ensuring rapid intervention by primary care physicians.
• A common step: Implement a hybrid approach to resocialization, combining Western models of vocational adaptation through social mobility mechanisms with Russian practices of occupational therapy in therapeutic communities, creating a comprehensive system for reintegrating individuals into society.

References to the sources used:

1. WHO Department for Work Related to Reducing the Burden Caused by Alcohol, Drugs and Addictive Behaviours
2. Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services
3. European Drug Report 2025
4. Opioid Agonist Treatment: Current Situation in Europe
5. Order of the Ministry of Health of the Russian Federation “On Approval of the Procedure for the Provision of Medical Care in the Field of ‘Psychiatry–Narcology’ and the Procedure for Dispensary Observation of Persons with Mental Disorders and Behavioral Disorders Associated with the Use of Psychoactive Substances” dated 30 December 2015 No. 1034n
6. Federal Law “On Narcotic Drugs and Psychotropic Substances” dated 08 January 1998 No. 3-FZ – https://normativ.kontur.ru/document?moduleId=1&documentId=475649
7. “Law on Psychiatric Care and Guarantees of Citizens’ Rights in Its Provision” dated 02 July 1992 No. 3185-I
8. Human Rights Watch Report on Human Rights in the Health Care Sector, 2007
9. Global Coverage of Interventions to Prevent and Treat Drug-Related Harm, published in Lancet Global Health, 2023
10. Rehabilitation in Narcology, A.V. Masyakin – Moscow Medicine, June 2024
11. Meta-analysis “Problems of Rehabilitation of Chemically Dependent Individuals in Domestic and Foreign Literature”, I.A. Dergach
12. Narcology: National Guidelines, edited by N.N. Ivanets et al., 2nd edition, revised and expanded